GENE ONLINE|News &
Opinion
Blog

Diabetes
In-Depth LawsuitEli LillyNovo Nordisk
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
M&A ObesityNovo NordiskCatalent
Novo Nordisk Acquire Catalent for $16.5 Billion, Enhancing Obesity Drugs Production Capacity
2024-02-07
Innovation Type 2 Diabeteshydrogel
Novel Hydrogel Delivery System Could Reduce Daily Diabetes Injections to Three Times a Year
2023-12-04
Partnerships diabetes treatmentInsulin
Amazon Pharmacy Implements Automated Discount Coupons Which Improved Insulin Affordability
2023-08-21
Trials & Approvals ObesityDiabetes
Lilly’s Oral GLP-1 Agonist Shows Encouraging Results for Weight Management
2023-06-28
Special WHO
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Partnerships Diabetes
Pfizer Begins Phase 2 Of Diabetes Drug, Triggering $10 Million Milestone To Sosei Heptares
2022-12-22
R&D Dementia
Oral Diabetes Drug May Protect Elderly From Dementia
2022-12-16
Trials & Approvals Merck
FDA Finds Carcinogen In Merck’s Diabetes Drug, Allows Continued Sales To Avoid Shortage
2022-08-11
Funding Financial TimesNovo Nordisk
Novo Nordisk Increased Sales by 25% in H1 2022
2022-08-03
R&D Evotec SE
Evotec Leverages Sernova’s Cell Pouch to Develop Diabetes Stem Cell Treatment
2022-05-18
Trials & Approvals Diabetes
Novo Nordisk’s Type 2 Diabetes Drug Gets Greenlight in Korea
2022-05-04
Trials & Approvals Kidney Disease
EU Greenlight for Bayer’s Kidney Disease Drug, Kicking off Market Rivalry Against Established SGLT-2 Inhibitors 
2022-03-01
Technology Diabetes
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
China Diabetes Mellitus
Diabetes Care Device Maker Debuts On Hong Kong Exchange
2021-10-20
LATEST
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
READ MORE
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top